Mylan reports profit, maintains commitment to acquire Perrigo
May 05, 2015 at 16:25 PM EDT
May 5 (Reuters) - Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, on Tuesday reported slightly higher-than-expected first-quarter profit and said it was "steadfast" in its commitment to acquire Ireland-based Perrigo Co.